SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-024440
Filing Date
2019-07-02
Accepted
2019-07-02 17:22:45
Documents
5
Period of Report
2019-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prtk-8k_20190627.htm 8-K 57615
2 EX-1.1 prtk-ex11_50.htm EX-1.1 302101
3 EX-5.1 prtk-ex51_6.htm EX-5.1 8830
4 EX-10.1 prtk-ex101_7.htm EX-10.1 443860
5 GRAPHIC gqxhd3hjrvkc000001.jpg GRAPHIC 3226
  Complete submission text file 0001564590-19-024440.txt   818491
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36066 | Film No.: 19939010
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1